Chemoinformaics analysis of Stigmasta-4,25-dien-3-one
| Molecular Weight | 410.686 | nRot | 6 |
| Heavy Atom Molecular Weight | 364.318 | nRig | 22 |
| Exact Molecular Weight | 410.355 | nRing | 4 |
| Solubility: LogS | -6.816 | nHRing | 0 |
| Solubility: LogP | 7.377 | No. of Aliphatic Rings | 4 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 4 |
| Atoms Count | 76 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 30 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 3 |
| No. of Hydrogen atom | 46 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 29 | No. of Saturated Rings | 3 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 79.9045 |
| nHD | 0 | BPOL | 47.0155 |
| QED | 0.404 |
| Synth | 4.52 |
| Natural Product Likeliness | 2.748 |
| NR-PPAR-gamma | 0.847 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.596 |
| Pgp-sub | 0 |
| HIA | 0.006 |
| CACO-2 | -4.809 |
| MDCK | 0.00000732 |
| BBB | 0.967 |
| PPB | 0.981764 |
| VDSS | 2.311 |
| FU | 0.0130193 |
| CYP1A2-inh | 0.081 |
| CYP1A2-sub | 0.545 |
| CYP2c19-inh | 0.114 |
| CYP2c19-sub | 0.934 |
| CYP2c9-inh | 0.164 |
| CYP2c9-sub | 0.501 |
| CYP2d6-inh | 0.011 |
| CYP2d6-sub | 0.893 |
| CYP3a4-inh | 0.387 |
| CYP3a4-sub | 0.688 |
| CL | 14.465 |
| T12 | 0.036 |
| hERG | 0.115 |
| Ames | 0.018 |
| ROA | 0.042 |
| SkinSen | 0.054 |
| Carcinogencity | 0.149 |
| EI | 0.011 |
| Respiratory | 0.963 |
| NR-Aromatase | 0.121 |
| Antiviral | No |
| Prediction | 0.639597 |